The tolerance and safety of intravenously administered benzyl alcohol in methylprednisolone sodium succinate formulations in normal human subjects.
D000328:Adult; D000438:Alcohols / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D001774:Blood Chemical Analysis; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004562:Electrocardiography; D004569:Electroencephalography; D006626:Hippurates / Q000652:urine; D006801:Humans; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000633:toxicity*; D010226:Parabens / Q000008:administration & dosage / Q000633:toxicity; D010592:Pharmaceutic Aids; D010919:Placebos; D012964:Sodium / Q000009:adverse effects; D013386:Succinates / Q000009:adverse effects; D013997:Time Factors
D000438:Alcohols; D001593:Benzyl Compounds; D004338:Drug Combinations; D006626:Hippurates; D010226:Parabens; D010592:Pharmaceutic Aids; D010919:Placebos; D013386:Succinates; D012964:Sodium; D008775:Methylprednisolone